Skip to main content
Bradley J. Katz
( out of 384 reviews )

Bradley J. Katz, MD, PhD

Languages spoken: English

Clinical Locations

  • Bradley Katz, MD, PhD, provides medical and surgical care of eye conditions,= including cataract, glaucoma, diabetes, and macular degeneration at the John A. Moran Eye Center, University of Utah, Salt Lake City. He specializes in neuro-ophthalmology and evaluates patients with diseases that affect the optic nerve, diseases that affect eye movements and neurologic diseases that affect vision. Dr. Katz’s research interests center around include light sensitivity (“photophobia”) and neurologic conditions associated with light sensitivity, such as migraine and blepharospasm.

    Get to know Dr. Katz by watching his profile video.

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 384 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 05, 2023
    MORAN EYE CENTER

    Very friendly and professional.

    August 05, 2023
    MORAN EYE CENTER

    Excellent

    August 04, 2023
    MORAN EYE CENTER

    Dr. Katz is an astounding doctor--his kindness, consideration, and expertise are beyond compare.

    August 04, 2023
    MORAN EYE CENTER

    He is ALWAYS good.

    August 04, 2023
    MORAN EYE CENTER

    Dr Katz is The Best. I have been a patient for many years. I trust him and rely on his judgment

    August 04, 2023
    MORAN EYE CENTER

    Dr Katz was pleasant and knowledgeable

    August 01, 2023
    MORAN EYE CENTER

    made certain that I understood what was happening

    July 20, 2023
    MORAN EYE CENTER

    He is very knowledgeable & interested in me as a person with severe eye problems

    July 18, 2023
    MORAN EYE CENTER

    Although I didn't spend much time with Dr. Katz, he listened to the test results provided by his assistants and recommended a procedure with Dr. Zaugg before my next appointment.

  • Bradley Katz, MD, PhD, provides medical and surgical care of eye conditions,= including cataract, glaucoma, diabetes, and macular degeneration at the John A. Moran Eye Center, University of Utah, Salt Lake City. He specializes in neuro-ophthalmology and evaluates patients with diseases that affect the optic nerve, diseases that affect eye movements and neurologic diseases that affect vision. Dr. Katz’s research interests center around include light sensitivity (“photophobia”) and neurologic conditions associated with light sensitivity, such as migraine and blepharospasm.

    Get to know Dr. Katz by watching his profile video.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Primary
    Neurology -Adjunct
    Board Certification
    National Board of Medical Examiners

    Education history

    Fellowship Neuro-Ophthalmology - University of Utah School of Medicine Fellow
    Ophthalmology - University of Iowa Hospitals and Clinics Resident
    Internship Internal Medicine - University of Illinois at Urbana - Champaign Intern
    Neuroscience - University of Illinois at Urbana - Champaign Ph.D.
    Professional Medical University of Illinois at Urbana - Champaign M.D.
    Biomedical Engineering - Northwestern University B.S.
    Undergraduate Electrical Engineering - Northwestern University B.S.

    Selected Publications

    Journal Article

    1. Katz BJ (2020). Put a Drop of Timolol Into Each Eye and Call Me in the Morning. JAMA Ophthalmol. (Read full article)
    2. Orme DR, Vegunta S, Miller MA, Warner JEA, Bair C, McFadden M, Crum AV, Digre KB, Katz BJ (2020). A Comparison Between the Clinical Features of Pseudotumor Cerebri Secondary to Tetracyclines and Idiopathic Intracranial Hypertension. Am J Ophthalmol, 220, 177-182. (Read full article)
    3. Hamann S, Malmqvist L, Wegener M, Biousse V, Bursztyn L, Citirak G, Costello F, Crum AV, Digre K, Fard MA, Fraser JA, Huna-Baron R, Katz B, Lawlor M, Newman NJ, Peragallo JH, Petzold A, Sibony PA, Subramanian PS, Warner JE, Wong SH, Fraser CL, Optic Disc Drusen Studies Consortium (2020). Young Adults with Anterior Ischemic Optic Neuropathy: A Multicenter Optic Disc Drusen Study. Am J Ophthalmol, 217, 174-181. (Read full article)
    4. Ozudogru S, Neufeld A, Katz BJ, Baggaley S, Pippitt K, Zhang Y, Digre KB (2019). Reduced Visual Quality of Life Associated with Migraine is Most Closely Correlated with Symptoms of Dry Eye. Headache, 59(10), 1714-1721. (Read full article)
    5. Cortez MM, Digre K, Uddin D, Hung M, Blitzer A, Bounsanga J, Voss MW, Katz BJ (2019). Validation of a photophobia symptom impact scale. Cephalalgia, 39(11), 1445-1454. (Read full article)
    6. Katz BJ (2018). Optic Nerve Head Drusen: The Relationship Between Intraocular Pressure and Optic Nerve Structure and Function: Comment. J Neuroophthalmol, 39(1), 143. (Read full article)
    7. Hu JY, Katz B (2018). Non-arteritic ischemic optic neuropathy and supplemental nitric oxide usage. Am J Ophthalmol Case Rep, 11, 26-27. (Read full article)
    8. Bowen RC, Koeppel JN, Christensen CD, Snow KB, Ma J, Katz BJ, Krauss HR, Landau K, Warner JEA, Crum AV, Straumann D, Digre KB (2018). The Most Common Causes of Eye Pain at 2 Tertiary Ophthalmology and Neurology Clinics. J Neuroophthalmol, 38(3), 320-327. (Read full article)
    9. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S (2018). The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography. J Neuroophthalmol, 38(3), 299-307. (Read full article)
    10. Hanson LL, Ahmed Z, Katz BJ, Warner JEA, Crum AV, Zhang Y, Zhang Y, Baggaley S, Pippitt K, Cortez MM, Digre KB (2018). Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life. Headache, 58(7), 1007-1013. (Read full article)
    11. Adesina OO, Scott McNally J, Salzman KL, Katz BJ, Warner JEA, McFadden M, Digre KB (2018). Diffusion-Weighted Imaging and Post-contrast Enhancement in Differentiating Optic Neuritis and Non-arteritic Anterior Optic Neuropathy. Neuroophthalmology, 42(2), 90-98. (Read full article)
    12. Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JE, McClane RW, Nandedkar SD, Langeberg WJ, Holubkov R, Katz BJ (2008). FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology, 116(5), 997-1001. (Read full article)
    13. Crow RW, Katz BJ, Warner JE, Alder SC, Zhang K, Schulman S, Digre KB (2009). Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci, 64(3), 365-9. (Read full article)
    14. Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ (2009). A comparison of idiopathic intracranial hypertension with and without papilledema. Headache, 49(2), 185-93. (Read full article)
    15. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB (2008). A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Retina, 28(10), 1478-86. (Read full article)
    16. Payne M, Yang Z, Katz BJ, Warner JE, Weight CJ, Zhao Y, Pearson ED, Treft RL, Hillman T, Kennedy RJ, Meire FM, Zhang K (2004). Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol, 138(5), 749-55. (Read full article)

    Letter

    1. Sibony PA, Biousse V, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser CL, Huna-Baron R, Katz B, Lawlor M, Malmqvist L, Newman NJ, Peragallo J, Petzold A, Subramanian PS, Warner JEA, Wegener M, Wong S, Hamann S, ODDS Consortium (2020). Comment on: Morphologic Features of Buried Optic Disc Drusen on En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. [Letter to the editor]. Am J Ophthalmol, 219, 369-370. (Read full article)
    2. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S (2018). Peripapillary Hyperreflective Ovoid Mass-Like Structures: Is It Optic Disc Drusen or Not?: Response. [Letter to the editor]. J Neuroophthalmol, 38(4), 568-570. (Read full article)

    Patent

    1. Blair S, Katz BJ (2019). Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles. U.S. Patent No. PCT/US2012/021500. Washington, D.C.:U.S. Patent and Trademark Office.